From DC to OC: How Politicians Shape the MedTech Landscape
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Prior to AdvaMed®, He was chief operating officer of the Biotechnology Innovation Organization (BIO), the world’s largest trade association representing biotechnology companies, and president of the BIO International Convention, the world’s largest biotech conference. Whitaker also previously served as chief of staff of the U.S. Department of Health & Human Services (HHS) – a cabinet agency with 67,000 employees and a budget of $550 billion – from 2003 to 2005. As HHS chief of staff, he managed the day-to-day operations of the department; led the department’s activities on all major policy and management issues and initiatives; and served as the top liaison to the White House on policy, management and political matters. He also served as assistant secretary for legislation at HHS from 2001 to 2003.
In this episode we talk about AdvaMed's work in Washington DC, the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, what to expect from the Medical Device User Fee Admendment (MDUFA), the Senate passage of legislation restoring programs that jumpstart early stage medtech innovation, and his upcoming engagement at Orange Tree's MedTech CEO Forum. Tune in for inspiration, strategy, and a glimpse into the minds driving tomorrow's MedTech revolution! Follow The Orange Tree MedTech Podcast: LinkedIn: https://www.linkedin.com/company/orangetreemedtech Follow Scott Johnson on: LinkedIn: https://www.linkedin.com/in/scott-johnson-mba-/ #Orangecounty #medtech #medicaldevice #oc #orangetreemedtechpodcast